Protective effect of Huang Gan formula in 5/6 nephrectomized rats by depressing the Wnt/β-catenin signaling pathway

被引:16
作者
Mo, Liqian [1 ]
Xiao, Xiaoyan [1 ]
Song, Shaolian [1 ]
Miao, Hui [2 ]
Liu, Shiting [1 ]
Guo, Dan [1 ]
Li, Xiao [3 ]
Bu, Can [1 ]
Hou, Lianbing [1 ]
Yang, Xixiao [1 ]
机构
[1] Southern Med Univ, Nanfang Hosp, Dept Pharm, Guangzhou 510515, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China
[3] Qingdao Univ, Sch Med, Affiliated Hosp, Dept Pharm, Qingdao 266071, Peoples R China
关键词
Huang Gan formula; traditional Chinese medicine; chronic kidney disease; Wnt/beta-catenin signaling pathway; EPITHELIAL-MESENCHYMAL TRANSITION; RENAL INTERSTITIAL FIBROSIS; BETA-CATENIN; FAILURE RATS; WNT; MECHANISMS; PROGRESSION; PARICALCITOL; EXPRESSION; INJURY;
D O I
10.2147/DDDT.S81157
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Huang Gan formula (HGF) is a new traditional Chinese herbal medicine created according to the basic theory of traditional Chinese medicine. The aim of this study is to evaluate the effects of HGF on chronic kidney disease and determine the mechanisms of action. The extract of HGF was prepared, and qualitative and quantitative determination of phytochemical was performed with quadrupole time-of-flight mass spectrometer and high-performance liquid chromatography. Sprague-Dawley rats (n=72) were submitted to 5/6 nephrectomy (Nx), and then respectively treated with uremic clearance granule, losartan, HGF low dose, HGF middle dose, and HGF high dose once per day for 12 weeks. The sham group of operated rats (n=22) was treated with normal saline or HGF middle dose as a background control group. Blood and urine biochemical parameters, renal tissue morphology, and mRNA and proteins of Wnt/beta-catenin signaling pathways were investigated. The results showed that the quality of the extraction process could be controlled, and a total of eight major compounds were identified and quantified. HGF could decrease the level of serum creatinine, blood urea nitrogen, and urine protein and increase the renal index and creatinine clearance rate in a dose-dependent manner. HGF also remarkably reduced the glomerulosclerosis and tubulointerstitial fibrosis by blocking the Wnt/beta-catenin signaling pathway through inhibiting the Wnt1, beta-catenin, transcription factor 4, and fibronectin 1 expressions, simultaneously measured through mRNA and protein levels in the remnant kidney. These results suggest that extraction of HGF could improve remnant renal function and possibly ameliorate glomerulosclerosis and tubulointerstitial fibrosis by depressing the Wnt/beta-catenin signaling pathway.
引用
收藏
页码:2867 / 2881
页数:15
相关论文
共 37 条
[1]   Wnt Pathway Activation in Long Term Remnant Rat Model [J].
Banon-Maneus, E. ;
Rovira, J. ;
Ramirez-Bajo, M. J. ;
Moya-Rull, D. ;
Hierro-Garcia, N. ;
Takenaka, S. ;
Diekmann, F. ;
Eickelberg, O. ;
Koenigshoff, M. ;
Campistol, J. M. .
BIOMED RESEARCH INTERNATIONAL, 2014, 2014
[2]   Emodin ameliorates glucose-induced matrix synthesis in human peritoneal mesothelial cells [J].
Chan, TM ;
Leung, JKH ;
Tsang, RCW ;
Liu, ZH ;
Li, LS ;
Yung, S .
KIDNEY INTERNATIONAL, 2003, 64 (02) :519-533
[3]   Cellular and molecular mechanisms in kidney fibrosis [J].
Duffield, Jeremy S. .
JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (06) :2299-2306
[4]   Overview of the cellular and molecular basis of kidney fibrosis [J].
Eddy, Allison A. .
KIDNEY INTERNATIONAL SUPPLEMENTS, 2014, 4 (01) :2-8
[5]   K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword [J].
Eknoyan, G ;
Levin, NW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) :S14-S266
[6]   Renal interstitial fibrosis: mechanisms and evaluation [J].
Farris, Alton B. ;
Colvin, Robert B. .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2012, 21 (03) :289-300
[7]   Restricted intake of dietary advanced glycation end products retards renal progression in the remnant kidney model [J].
Feng, J. X. ;
Hou, F. F. ;
Liang, M. ;
Wang, G. B. ;
Zhang, X. ;
Li, H. Y. ;
Xie, D. ;
Tian, J. W. ;
Liu, Z. Q. .
KIDNEY INTERNATIONAL, 2007, 71 (09) :901-911
[8]   Mechanisms of progression of chronic kidney disease [J].
Fogo, Agnes B. .
PEDIATRIC NEPHROLOGY, 2007, 22 (12) :2011-2022
[9]   Glycogen synthase kinase 3β:: A novel marker and modulator of inflammatory injury in chronic renal allograft disease [J].
Gong, R. ;
Ge, Y. ;
Chen, S. ;
Liang, E. ;
Esparza, A. ;
Sabo, E. ;
Yango, A. ;
Gohh, R. ;
Rifai, A. ;
Dworkin, L. D. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (09) :1852-1863
[10]   The Wnt antagonist DICKKOPF-1 gene is a downstream target of β-catenin/TCF and is downregulated in human colon cancer [J].
Gonzálex-Sancho, JM ;
Aguilera, O ;
García, JM ;
Pendás-Franco, N ;
Peña, C ;
Cal, S ;
de Herreros, AG ;
Bonilla, F ;
Muñoz, A .
ONCOGENE, 2005, 24 (06) :1098-1103